Can a VR seaside meditation lift depression that pills Can't?

NCT ID NCT07422519

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding virtual reality (VR) mindfulness sessions to standard treatment can help people with treatment-resistant depression feel better. Thirty adults who haven't responded to multiple antidepressants will either get usual care alone or usual care plus 8 VR-guided meditations over a month. Researchers will track depression severity, side effects, and how long any improvement lasts.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Virtual reality-based mindfulness meditation
What this could lead to
If it works, this could offer a new, drug-free option to help ease depression symptoms for people who haven't responded to standard treatments.
What could go wrong
This is a very small pilot study with only 30 people, so results may not apply widely. The VR mindfulness is added to usual care, not a replacement, and its benefits are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION - MAJOR DEPRESSIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

depressive disorder Depressive Disorder, Treatment-Resistant major depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hospital Universitari Vall d'Hebron

    RECRUITING

    Barcelona, 08035, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.